Valuation: Becton, Dickinson and Company

Market Cap 51.11B 43.78B 40.96B 37.49B 70.37B 4,890B 71.3B 484B 189B 2,456B 192B 188B 8,125B P/E 2026 *
36.2x
P/E 2027 * 20.2x
Enterprise Value 66.99B 57.38B 53.69B 49.15B 92.24B 6,410B 93.46B 634B 247B 3,220B 252B 246B 10,650B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.3x
Free-Float
73.18%
Yield 2026 *
2.09%
Yield 2027 * 2.13%
1 day+1.76%
1 week+4.30%
Current month+15.50%
1 month+24.34%
3 months+30.80%
6 months+3.77%
Current year-1.43%
1 week 180.72
Extreme 180.72
191.77
1 month 152.13
Extreme 152.13
191.77
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.5
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
8/13/26 Fiscal year

Chief Executive Officer

129,834 0.0471%
8/11/26 Sell

EVP and President, EMEA

-2,438 0.0009%
8/6/26 Free

Director

189 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+4.30%-2.72%-30.60% 51.11B
+1.98%+4.53%-11.90%+11.96% 198B
+0.95%+1.74%+1.93%+13.79% 118B
+1.19%+1.60%+5.14%+76.17% 60.05B
-1.37%-6.27%+28.79%+60.98% 53.18B
+1.44%+1.99%+13.55%-12.55% 34.05B
+4.34%-5.16% - - 28.58B
-0.14%+1.06%+45.54%-10.07% 24.9B
+0.71%+1.80%-4.05%+6.60% 22.98B
-0.29%-1.97%-7.07%+24.56% 23.94B
Average +1.05%-0.50%+7.69%+15.65% 61.44B
Weighted average by Cap. +1.25%+0.73%+1.56%+17.59%

Financials

2026 *2027 *
Net sales 19.29B 16.52B 15.46B 14.15B 26.56B 1,846B 26.91B 183B 71.24B 927B 72.44B 70.86B 3,067B 19.73B 16.9B 15.82B 14.48B 27.17B 1,888B 27.53B 187B 72.87B 948B 74.1B 72.48B 3,137B
Net income 1.44B 1.23B 1.15B 1.05B 1.98B 137B 2B 13.6B 5.31B 69.05B 5.39B 5.28B 228B 2.34B 2B 1.88B 1.72B 3.22B 224B 3.26B 22.15B 8.64B 112B 8.78B 8.59B 372B
Net Debt 15.88B 13.61B 12.73B 11.65B 21.87B 1,520B 22.16B 150B 58.66B 763B 59.65B 58.35B 2,525B 13.95B 11.95B 11.18B 10.24B 19.21B 1,335B 19.46B 132B 51.52B 671B 52.39B 51.25B 2,218B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-21 $190.69 +1.64% 1,083,566
26-08-20 $187.62 +0.01% 1,972,683
26-08-19 $187.60 +3.78% 2,164,452
26-08-18 $180.77 -0.72% 1,616,422
26-08-17 $182.09 -0.71% 1,310,491
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
187.62USD
Average target price
194.42USD
Spread / Average Target
+3.62%

Quarterly revenue - Rate of surprise